LifeScience WorldWide’s Post

Finally completed the course on introduction to small molecule in drug discovery. Step by step progress.

Are you at EuroQSAR? Join us at the poster session! Stop by to ask questions, explore the science behind our platform, and learn how we’re pushing the boundaries of early-stage drug discovery! Find us at poster #P005 and let's talk innovation.

ICYMI: Dan Smithey, PhD and four experienced c-level executives from leading development, technology, manufacturing and bioprocess partner organizations sat down with Kurt Nielsen to discuss the innovations needed to get your molecule to market in these challenging times. Why do we need to innovate? ""As molecules get more complex, they require more technology and innovation to be absorbed or delivered properly. Ultimately, drug development partners have to adopt new technologies to help our clients be successful. If we aren't technology aggressive, we simply won't be able to deliver successful medicines."", Dan Smithey, CEO Listen to the entire panel discussion here:https://hubs.li/Q02k-hdK0 #drugdevelopment #drugmanufacturing #partner #cdmo

📢 Today, we're at the BioTechX event in Switzerland. Speak to Ahmed EL-RAYIS, PhD if you would like to book a meeting to discuss how MDC can help support your drug discovery project. #DrugDiscovery

Missed BIOVIA Live 2024 in North America? No worries! Our next event is happening in Europe, and we can't wait to see you there! 🚀 Connect with fellow industry experts to discuss and share actionable insights on the latest topics at BIOVIA Live 2024, including: - Lab of the Future - Materials Innovation - Formulations - Biopharma Quality and Regulatory - Manufacturing Analytics - Informatics and Data Science - Drug Discovery Development Register here: http://go.3ds.com/H5e . #BIOVIALive

What if there was a way to short-cut some of the elements in your drug development process and get a head start… Well, maybe there is 😀 These are Hanne Wulff Nielsen’s, VP Drug Development Counselling at KLIFO, top five recommendations to an early stage biotech company wanting to get a head start: 1️⃣ Know what you’re developing Prioritise developing a target product profile (TPP). It acts as a blueprint, keeping the development focused and goal-oriented, and it demonstrates to investors that you have a well-thought-out strategy for your product’s success. 2️⃣ Focus on robust preclinical data Before diving into clinical trials, ensure your preclinical data is strong. This foundation is critical to secure funding, attract partners, and set your program up for success. 3️⃣ Prioritize scalable processes From day one, design your manufacturing processes with scalability in mind. What works at the bench may not translate seamlessly to larger scales. Early investment in robust, scalable processes will save time and resources later on. 4️⃣ Develop a clear regulatory strategy Take advantage of the opportunity to engage with regulatory bodies, and take your time to plan well for advice meetings. This can save time, reduce costs, and increase the likelihood of approval down the line. 5️⃣ Build a strong team Involve experts who can bring diverse perspectives and are experienced in navigating drug development, from scientific innovation to business acumen. Feel free to reach out to Hanne if you want to discuss how to get started on the drug development process 📱 📧 #Biotech #DrugDevelopment #TPP #RegulatoryAffairs #KLIFO

In the world of drug discovery, where the journey from concept to cure is fraught with formidable challenges, science and strategy must intertwine to make leaps in medicine. The reality is stark: 9 out of 10 drugs fall by the wayside on the journey to approval. It's a high-stakes game with an average investment of $2.5 billion to usher a successful drug into the market. At Aspen Biosciences, we understand the intricacies of this process. That's why we created the Pipeline Program Management platform. Let us show you how Pipeline can revolutionize your drug discovery operations and improve the productivity of your team. Reach out for a demonstration and join us in our commitment to turn innovative concepts into life-saving realities. #DrugDiscovery #Innovation #ResearchAndDevelopment #AspenBiosciences #PipelineProgram #Biotech #PharmaIndustry #StrategicPlanning

In the world of drug discovery, where the journey from concept to cure is fraught with formidable challenges, science and strategy must intertwine to make leaps in medicine. The reality is stark: 9 out of 10 drugs fall by the wayside on the journey to approval. It's a high-stakes game with an average investment of $2.5 billion to usher a successful drug into the market. At Aspen Biosciences, we understand the intricacies of this process. That's why we created the Pipeline Program Management platform. Let us show you how Pipeline can revolutionize your drug discovery operations and improve the productivity of your team. Reach out for a demonstration and join us in our commitment to turn innovative concepts into life-saving realities. #DrugDiscovery #Innovation #ResearchAndDevelopment #AspenBiosciences #PipelineProgram #Biotech #PharmaIndustry #StrategicPlanning

Really interesting discussion to hear in case you missed it!

Interesting update from Disruptive Pharma AB on #MMC #Upsalite for drug delivery. The video is definitely worth a watch. Looking forward to the future developments. #PharmaInnovation #Healthcare #drugdelivery #drugformulation #biovailability